Sign in

CIK 0001659617 · Non-accelerated filer<br>Smaller reporting company

Moleculin Biotech, Inc.

Sign in to watch
Ticker
MBRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474671997
Phone
713-300-5160
Business address
5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Regulation FD disclosure
  3. SCHEDULE 13D Stake Beneficial Ownership Report
  4. SCHEDULE 13D Stake Beneficial Ownership Report
  5. DEFA14A Proxy Proxy Materials
  6. DEF 14A Proxy Proxy Statement
  7. 424B5 Offering Prospectus
  8. PRE 14A Proxy Proxy Statement (Preliminary)
  9. 8-K Event Results of operations
  10. 10-Q Report Quarterly Report
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 8-K Event Material agreement
  17. 424B5 Offering Prospectus
  18. EFFECT Other Notice of Effectiveness
  19. 8-K Event Regulation FD disclosure
  20. S-1/A Offering Registration Statement

Page 2 of 43 · 843 filings